Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$12.09−0.09 (-0.74%)
Close on Nov 18, 2026Market cap $1.82BP/E –Yield 4.24%
Chemours gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Chemours's gross profit for the twelve months ending Jun 30, 2026 was $887.00M, down 16.7% year over year. For fiscal 2025 it was $902.00M, down 21.0% from the year before. Over ten years it grew -0.6% a year on average. The highest annual figure on record is $1.97B in fiscal 2018.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $902.00M | -21.0% |
| FY2024 | Dec 31, 2024 | $1.14B | -12.3% |
| FY2023 | Dec 31, 2023 | $1.30B | -19.4% |
| FY2022 | Dec 31, 2022 | $1.62B | +17.0% |
| FY2021 | Dec 31, 2021 | $1.38B | +29.4% |
| FY2020 | Dec 31, 2020 | $1.07B | +0.4% |
| FY2019 | Dec 31, 2019 | $1.06B | -46.1% |
| FY2018 | Dec 31, 2018 | $1.97B | +13.0% |
| FY2017 | Dec 31, 2017 | $1.75B | +58.2% |
| FY2016 | Dec 31, 2016 | $1.10B | +15.5% |
| FY2015 | Dec 31, 2015 | $955.00M | -29.8% |
| FY2014 | Dec 31, 2014 | $1.36B | -7.1% |
| FY2013 | Dec 31, 2013 | $1.46B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $286.00M | +2.9% |
| Q1 FY2026 | Mar 31, 2026 | $212.00M | -10.2% |
| Q4 FY2025 | Dec 31, 2025 | $156.00M | -41.1% |
| Q3 FY2025 | Sep 30, 2025 | $233.00M | -18.5% |
| Q2 FY2025 | Jun 30, 2025 | $278.00M | -9.7% |
| Q1 FY2025 | Mar 31, 2025 | $236.00M | -16.9% |
| Q4 FY2024 | Dec 31, 2024 | $265.00M | +5.6% |
| Q3 FY2024 | Sep 30, 2024 | $286.00M | +4.8% |
| Q2 FY2024 | Jun 30, 2024 | $308.00M | -24.9% |
| Q1 FY2024 | Mar 31, 2024 | $284.00M | -22.8% |
| Q4 FY2023 | Dec 31, 2023 | $251.00M | +24.3% |
| Q3 FY2023 | Sep 30, 2023 | $273.00M | -36.8% |
| Q2 FY2023 | Jun 30, 2023 | $410.00M | -17.5% |
| Q1 FY2023 | Mar 31, 2023 | $368.00M | -24.3% |
| Q4 FY2022 | Dec 31, 2022 | $202.00M | -48.6% |
| Q3 FY2022 | Sep 30, 2022 | $432.00M | +1.2% |
| Q2 FY2022 | Jun 30, 2022 | $497.00M | +88.3% |
| Q1 FY2022 | Mar 31, 2022 | $486.00M | +63.6% |
| Q4 FY2021 | Dec 31, 2021 | $393.00M | +25.6% |
| Q3 FY2021 | Sep 30, 2021 | $427.00M | +66.1% |
| Q2 FY2021 | Jun 30, 2021 | $264.00M | +32.7% |
| Q1 FY2021 | Mar 31, 2021 | $297.00M | -0.3% |
| Q4 FY2020 | Dec 31, 2020 | $313.00M | +108.7% |
| Q3 FY2020 | Sep 30, 2020 | $257.00M | -12.6% |
| Q2 FY2020 | Jun 30, 2020 | $199.00M | -38.4% |
| Q1 FY2020 | Mar 31, 2020 | $298.00M | +0.7% |
| Q4 FY2019 | Dec 31, 2019 | $150.00M | -62.5% |
| Q3 FY2019 | Sep 30, 2019 | $294.00M | -38.4% |
| Q2 FY2019 | Jun 30, 2019 | $323.00M | -42.0% |
| Q1 FY2019 | Mar 31, 2019 | $296.00M | -44.9% |
| Q4 FY2018 | Dec 31, 2018 | $400.00M | -17.4% |
| Q3 FY2018 | Sep 30, 2018 | $477.00M | +2.6% |
| Q2 FY2018 | Jun 30, 2018 | $557.00M | +27.2% |
| Q1 FY2018 | Mar 31, 2018 | $537.00M | +50.8% |
| Q4 FY2017 | Dec 31, 2017 | $484.00M | +65.8% |
| Q3 FY2017 | Sep 30, 2017 | $465.00M | +36.0% |
| Q2 FY2017 | Jun 30, 2017 | $438.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $356.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $292.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $342.00M | – |
See a number that looks wrong?